» Articles » PMID: 39548411

U-shaped Relationship Between Triglyceride Glucose-body Mass Index and Suicide Attempts in Chinese Patients with Untreated First-episode Major Depressive Disorder

Overview
Journal BMC Psychiatry
Publisher Biomed Central
Specialty Psychiatry
Date 2024 Nov 16
PMID 39548411
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: An alternative metric for evaluating insulin resistance (IR) is the triglyceride glucose-body mass index (TyG-BMI). However, it is yet unclear how TyG-BMI and suicide attempts (SA) are related. The objective of this research was to explore the correlation between the TyG-BMI index and SA in individuals with untreated first-episode (UFE) major depressive disorder (MDD) in Shanxi Province.

Methods: This cross-sectional study was conducted from September 2016 to December 2018 in the psychiatric outpatient clinic of Taiyuan General Hospital and included 1718 patients with UFE MDD, with a mean age of 34.9 ± 12.4 years. The relationship between TyG-BMI and SA was assessed using logistic regression modeling. We investigated threshold effects using a two-piecewise linear regression model.

Results: Taking into consideration the potential influence of confounding variables, a comprehensive multivariate logistic regression analysis was conducted, which demonstrated the absence of a statistically significant association between the TyG-BMI index and the occurrence of SA, as evidenced by P-values that were all greater than 0.05. On the other hand, the visual analysis of the smoothed plots revealed a U-shaped relationship between the TyG-BMI index and the incidence of SA, with a notable inflection occurring at a TyG-BMI value of around 210. It was observed that the effect sizes flanking the inflection point, accompanied by their 95% confidence intervals, were 0.985 (95% CI: 0.972 to 0.999, P = 0.031) and 1.012 (95% CI: 1.003 to 1.047, P = 0.005), respectively.

Conclusions: In UFE MDD patients, a U-shaped link was observed between TyG-BMI and SA, with the minimal SA incidence noted at a TyG-BMI level of 210, signifying that an augmented risk for SA might be connected to both diminished and augmented TyG-BMI levels.

References
1.
Rasgon N, Kenna H, Williams K, Powers B, Wroolie T, Schatzberg A . Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. ScientificWorldJournal. 2010; 10:321-8. PMC: 5763944. DOI: 10.1100/tsw.2010.32. View

2.
Morigny P, Houssier M, Mouisel E, Langin D . Adipocyte lipolysis and insulin resistance. Biochimie. 2015; 125:259-66. DOI: 10.1016/j.biochi.2015.10.024. View

3.
Song B, Zhao X, Yao T, Lu W, Zhang H, Liu T . Triglyceride Glucose-Body Mass Index and Risk of Incident Type 2 Diabetes Mellitus in Japanese People With Normal Glycemic Level: A Population-Based Longitudinal Cohort Study. Front Endocrinol (Lausanne). 2022; 13:907973. PMC: 9336540. DOI: 10.3389/fendo.2022.907973. View

4.
Shi Y, Zheng R, Cai J, Qian S . The association between triglyceride glucose index and depression: data from NHANES 2005-2018. BMC Psychiatry. 2021; 21(1):267. PMC: 8146990. DOI: 10.1186/s12888-021-03275-2. View

5.
Lopez-Gambero A, Martinez F, Salazar K, Cifuentes M, Nualart F . Brain Glucose-Sensing Mechanism and Energy Homeostasis. Mol Neurobiol. 2018; 56(2):769-796. DOI: 10.1007/s12035-018-1099-4. View